Effect of Carbenoxolone on Arrhythmogenesis in Rat Ventricular Muscle.
BACKGROUND
Connexin43 (Cx43) is a major connexin that forms gap junction (GJ) channels in the heart and is also present in the cell membrane as unopposed/non-junctional hemichannels and in the inner mitochondrial membrane. By using carbenoxolone (CBX), a blocker of Cx43, the effect of the blockade of Cx43 on Ca(2+)waves and triggered arrhythmias in the myocardium with non-uniform contraction was examined.


RESULTS
Trabeculae were obtained from rat hearts. Force, [Ca(2+)]i, and the diffusion coefficient were measured. Non-uniform contraction was produced with a 2,3-butanedione monoxime jet. Ca(2+)waves were induced by electrical stimulation. Inducibility of arrhythmias was estimated based on the minimal [Ca(2+)]oat which arrhythmias were induced. The Ca(2+)spark rate was measured in isolated single rat ventricular myocytes. CBX reduced the GJ permeability, whereas it did not change force and [Ca(2+)]itransients. CBX increased the Ca(2+)leak from the sarcoplasmic reticulum in trabeculae and increased the Ca(2+)spark rate in isolated single myocytes. CBX increased the velocity of Ca(2+)waves and further increased the inducibility of arrhythmias. Modulation of mitochondrial KATPchannels by diazoxide, cromakalim and 5-hydroxydecanoic acid affected the inducibility of arrhythmias increased by CBX.


CONCLUSIONS
These results suggest that in diseased hearts, Cx43 plays an important role in the occurrence of triggered arrhythmias, probably under the modulation of mitochondrial KATPchannels.
Department of Clinical Physiology, Health Science, Tohoku University Graduate School of Medicine.
Masahito
M
Miura
Tsuyoshi
T
Nagano
Naomi
N
Murai
Yuhto
Y
Taguchi
Tetsuya
T
Handoh
Minami
M
Satoh
Satoshi
S
Miyata
Lawson
L
Miller
Chiyohiko
C
Shindoh
Bruno D
BD
Stuyvers
D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000378:metabolism* / Q000503:physiopathology; D002118:Calcium / Q000378:metabolism; D020013:Calcium Signaling / Q000187:drug effects*; D002229:Carbenoxolone / Q000009:adverse effects* / Q000494:pharmacology; D018031:Connexin 43 / Q000378:metabolism; D006352:Heart Ventricles / Q000378:metabolism* / Q000503:physiopathology; D009206:Myocardium / Q000378:metabolism*; D032383:Myocytes, Cardiac / Q000378:metabolism*; D051381:Rats
D018031:Connexin 43; C580592:Gja1 protein, rat; D002229:Carbenoxolone; D002118:Calcium